Clearance of von Willebrand factor

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

(2013) J. Eikenboom et al.   BLOOD

von Willebrand disease: Clinical and laboratory lessons learned from the large von Willebrand disease studies

(2012) Paula D. James et al.   AMERICAN JOURNAL OF HEMATOLOGY

Mapping the N-glycome of human von Willebrand factor

(2012) Kevin Canis et al.   BIOCHEMICAL JOURNAL

Sequence and structure relationships within von Willebrand factor

(2012) Y.-F. Zhou et al.   BLOOD

Macrophage LRP1 contributes to the clearance of von Willebrand factor

(2012) G. Rastegarlari et al.   BLOOD

Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5

(2012) J. N. Pegon et al.   HAEMATOLOGICA

von Willebrand factor: the old, the new and the unknown

(2012) P. J. LENTING et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older population

(2012) J. E. van LOON et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Shear stress is required for the endocytic uptake of the factor VIII-von Willebrand factor complex by macrophages

(2012) L. CASTRO-NÚÑEZ et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes

(2012) Q. Y. Wang et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Cross Talk between Engulfment Receptors Stabilin-2 and Integrin  v 5 Orchestrates Engulfment of Phosphatidylserine-Exposed Erythrocytes

(2012) S. Kim et al.   MOLECULAR AND CELLULAR BIOLOGY

In Vivo Analysis of the Role of O-Glycosylations of Von Willebrand Factor

(2012) Idinath Badirou et al.   PLoS One

Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association

(2012) K. C. Desch et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Challenges and Opportunities for Cardiovascular Disease Prevention

(2011) Manuel Franco et al.   AMERICAN JOURNAL OF MEDICINE

Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort

(2011) M. Campos et al.   BLOOD

Functional architecture of Weibel-Palade bodies

(2011) K. M. Valentijn et al.   BLOOD

Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models

(2011) C. M. Pruss et al.   BLOOD

Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels

(2011) Guillemette Antoni et al.   BMC Medical Genetics

Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review

(2011) M. C. VAN SCHIE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Adaptive Evolution of the Venom-Targeted vWF Protein in Opossums that Eat Pitvipers

(2011) Sharon A. Jansa et al.   PLoS One

Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance

(2011) Alberto Tosetto et al.   THROMBOSIS AND HAEMOSTASIS

Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B

(2010) J. Rayes et al.   BLOOD

Variation in the von Willebrand factor gene is associated with von Willebrand factor levels and with the risk for cardiovascular disease

(2010) M. C. van Schie et al.   BLOOD

Platelet von Willebrand factor - structure, function and biological importance

(2010) Rachel T. McGrath et al.   BRITISH JOURNAL OF HAEMATOLOGY

Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor

(2010) Nicholas L. Smith et al.   CIRCULATION

Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans

(2010) Ana Knežević et al.   GLYCOBIOLOGY

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia

(2010) A. Casonato et al.   HAEMATOLOGICA

A novel alanine or threonine 789 to proline mutation causing type 2N von Willebrand’s disease when inherited homozygously or heterozygously with arginine 854 to glutamine mutation

(2010) M. S. ENAYAT et al.   HAEMOPHILIA

Blood group significantly influences von Willebrand factor increase and half-life after desmopressin in von Willebrand disease Vicenza

(2010) G. CASTAMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza

(2010) A. GÉZSI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Functional variation in the arginine vasopressin 2 receptor as a modifier of human plasma von Willebrand factor levels

(2010) A. Y. NOSSENT et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

von Willebrand factor clearance does not involve proteolysis by ADAMTS-13

(2010) I. BADIROU et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Effect of the VWF promoter (GT)n repeat and single-nucleotide polymorphism c.-2527G>A on circulating von Willebrand factor levels under normal conditions

(2010) N. HICKSON et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Rat and human HARE/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins

(2009) Edward N. Harris et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The plasma von Willebrand factorO-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs

(2009) K. CANIS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Models for Prediction of Factor VIII Half-Life in Severe Haemophiliacs: Distinct Approaches for Blood Group O and Non-O Patients

(2009) Kathelijn Fischer et al.   PLoS One

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

(2008) S. L. Haberichter et al.   BLOOD

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor

(2008) L. Gallinaro et al.   BLOOD

Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients

(2008) A. B. Federici et al.   BLOOD

Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo

(2008) C. J. van Schooten et al.   BLOOD

Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease

(2008) M. Sztukowska et al.   BRITISH JOURNAL OF HAEMATOLOGY

The Ashwell receptor mitigates the lethal coagulopathy of sepsis

(2008) Prabhjit K Grewal et al.   NATURE MEDICINE

LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies

(2008) Anna P. Lillis et al.   PHYSIOLOGICAL REVIEWS

Low density lipoprotein receptor-related protein polymorphisms are not risk factors for venous thromboembolism

(2007) Tayana B.T. Mello et al.   THROMBOSIS RESEARCH